Indications and uses
temporary relief of corneal edema
temporary relief of corneal edema
Instill 1 or 2 drops in the affected eye(s) every 3 or 4 hours, or as directed by a doctor.
Sodium chloride 2%
Hypertonicity agent
temporary relief of corneal edema
For external use only
Do not use
When using this product
Stop use and ask a doctor if
If swallowed, get medical help or contact a Poison Control Center right away.
boric acid, hypromellose, methylparaben, propylene glycol, propylparaben, purified water, sodium borate. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH.
[telephone icon] Call 1-800-553-5340
Muro 128 is a trademark of Bausch & Lomb Incorporated or its affiliates.
© 2022 Bausch & Lomb Incorporated or its affiliates
Marketed by:
Bausch & Lomb Americas Inc.
Bridgewater, NJ 08807 USA
9756801
AB15511
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 750137 | Muro 128 2 % Ophthalmic Solution | PSN | 8 |
| 750121 | sodium chloride 2 % Ophthalmic Solution | PSN | 8 |
| 750137 | sodium chloride 0.342 MEQ/ML Ophthalmic Solution [Muro 128] | SBD | 8 |
| 750121 | sodium chloride 0.342 MEQ/ML Ophthalmic Solution | SCD | 8 |
| 750137 | Muro 128 0.342 MEQ/ML Ophthalmic Solution | SY | 8 |
| 750137 | Muro 2 % Ophthalmic Solution | SY | 8 |
| 750121 | NaCl 0.342 MEQ/ML Ophthalmic Solution | SY | 8 |
| 750137 | NaCl 0.342 MEQ/ML Ophthalmic Solution [Muro 128] | SY | 8 |
| 750121 | sodium chloride 2 % Ophthalmic Solution | SY | 8 |
| Class | Version | Type | Effective |
|---|---|---|---|
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-276-15 | Muro 128 | 1 in 1 CARTON | SOLUTION | 1 | 8 | |
| 24208-276-15 | Muro 128 | 15 mL in 1 BOTTLE | SOLUTION | 15 | 8 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-276-15 | ML - Milliliter | 24208-276 | 5736b381-bb14-49e1-bc22-5002c116a355 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 3 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 3 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 3 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 3 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 3 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24208-276 | 24208-276-15 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / OPHTHALMIC | 0.31 %w/v | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / OPHTHALMIC | 60 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION / OPHTHALMIC | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / OPHTHALMIC | 60 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / OPHTHALMIC | 0.31 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION / OPHTHALMIC | 2 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Muro 128 | SODIUM CHLORIDE | Bausch & Lomb Incorporated | cc3d5bc8-9d3c-4c65-9e43-707a2db4081a | 2024-09-25 | Warnings | 24208-276-15 24208-276 24208027615 22f593c0-980c-0fc9-e063-6394a90a445d cc3d5bc8-9d3c-4c65-9e43-707a2db4081a |
Adverse event summaries are temporarily unavailable. Other product information remains available.